Published in Blood Weekly, June 17th, 1996
The OraSure technology - which does not require blood or needles - provides a simple and accurate HIV testing option. OraSure was developed by Epitope, Inc., Pittsburgh, Pennsylvania, and has been planned for marketing to health professionals by SmithKline Beecham Consumer Healthcare (SBCH).
Richard Sadovsky, M.D., State University of New York Health Science Center at Brooklyn, said, "HIV antibody testing is one of the strongest weapons we have to wage war on the spread of AIDS, and this painless new testing option is likely to have...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.